November 15, 2018 / News / Comments Off on Neo-Adjuvant Therapy Working Group

Dear Pancreatobiliary Pathology Society Members,

Neoadjuvant therapy is increasingly used for the treatment of pancreatic cancer. Resection specimens that have undergone such treatment pose substantial diagnostic, staging, prognostic and reporting challenges. These issues have been raised at past PBPS meetings as some of the more challenging areas in our field that require further standardization.

In order to address this, PBPS has created a new working group, the Neo-Adjuvant Therapy Working Group, whose role will be to tackle these issues. After reviewing the many highly qualified applicants for membership, we selected the following new members and look forward to learning from them.

Co-Chairs:

Dr. Runjan Chetty from Toronto General Hospital, Canada

Dr. Huamin Wang from MD Anderson Cancer Center, USA

Members:

Daniela Allende from Cleveland Clinic, USA

Dr. Irene Esposito from Heinrich-Heine University of Duesseldorf, Germany